TY - JOUR AU - Goodman, W. G. AU - Goldin, J. AU - Kuizon, B. D. PY - 2000 DA - 2000// TI - Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis JO - N Engl J Med VL - 342 UR - https://doi.org/10.1056/NEJM200005183422003 DO - 10.1056/NEJM200005183422003 ID - Goodman2000 ER - TY - JOUR AU - Block, G. A. AU - Klassen, P. S. AU - Lazarus, J. M. AU - Ofsthun, N. AU - Lowrie, E. G. AU - Chertow, G. M. PY - 2004 DA - 2004// TI - Mineral metabolism, mortality, and morbidity in maintenance hemodialysis JO - J Am Soc Nephrol VL - 15 UR - https://doi.org/10.1097/01.ASN.0000133041.27682.A2 DO - 10.1097/01.ASN.0000133041.27682.A2 ID - Block2004 ER - TY - JOUR AU - Kestenbaum, B. AU - Sampson, J. N. AU - Rudser, K. D. PY - 2005 DA - 2005// TI - Serum phosphate levels and mortality risk among people with chronic kidney disease JO - J Am Soc Nephrol VL - 16 UR - https://doi.org/10.1681/ASN.2004070602 DO - 10.1681/ASN.2004070602 ID - Kestenbaum2005 ER - TY - JOUR AU - Melamed, M. L. AU - Eustace, J. A. AU - Plantinga, L. PY - 2006 DA - 2006// TI - Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study JO - Kidney Int VL - 70 UR - https://doi.org/10.1038/sj.ki.5001542 DO - 10.1038/sj.ki.5001542 ID - Melamed2006 ER - TY - JOUR AU - Tentori, F. AU - Blayney, M. J. AU - Albert, J. M. PY - 2008 DA - 2008// TI - Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS) JO - Am J Kidney Dis VL - 52 UR - https://doi.org/10.1053/j.ajkd.2008.03.020 DO - 10.1053/j.ajkd.2008.03.020 ID - Tentori2008 ER - TY - JOUR AU - Fukagawa, M. AU - Yokoyama, K. AU - Koiwa, F. PY - 2013 DA - 2013// TI - Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder JO - Ther Apher Dial VL - 17 UR - https://doi.org/10.1111/1744-9987.12058 DO - 10.1111/1744-9987.12058 ID - Fukagawa2013 ER - TY - JOUR AU - Finn, W. F. PY - 2006 DA - 2006// TI - Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: safety and efficacy in chronic maintenance hemodialysis patients JO - Clin Nephrol VL - 65 UR - https://doi.org/10.5414/CNP65191 DO - 10.5414/CNP65191 ID - Finn2006 ER - TY - JOUR AU - Hutchison, A. J. AU - Maes, B. AU - Vanwalleghem, J. PY - 2006 DA - 2006// TI - Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study JO - Nephron Clin Pract VL - 102 UR - https://doi.org/10.1159/000088932 DO - 10.1159/000088932 ID - Hutchison2006 ER - TY - JOUR AU - Hutchison, A. J. AU - Barnett, M. E. AU - Krause, R. AU - Kwan, J. T. AU - Siami, G. A. PY - 2008 DA - 2008// TI - Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment JO - Nephron Clin Pract VL - 110 UR - https://doi.org/10.1159/000149239 DO - 10.1159/000149239 ID - Hutchison2008 ER - TY - JOUR AU - Shigematsu, T. AU - Group, L. C. R. PY - 2010 DA - 2010// TI - Three-year extension study of lanthanum carbonate therapy in Japanese hemodialysis patients JO - Clin Exp Nephrol VL - 14 UR - https://doi.org/10.1007/s10157-010-0339-3 DO - 10.1007/s10157-010-0339-3 ID - Shigematsu2010 ER - TY - JOUR AU - Canavese, C. AU - Mereu, C. AU - Nordio, M. AU - Sabbioni, E. AU - Aime, S. PY - 2005 DA - 2005// TI - Blast from the past: the aluminum’s ghost on the lanthanum salts JO - Curr Med Chem VL - 12 UR - https://doi.org/10.2174/0929867054367158 DO - 10.2174/0929867054367158 ID - Canavese2005 ER - TY - JOUR AU - Molony, D. A. AU - Murthy, B. PY - 2005 DA - 2005// TI - Accumulation of metals and minerals from phosphate binders JO - Blood Purif VL - 23 UR - https://doi.org/10.1159/000083712 DO - 10.1159/000083712 ID - Molony2005 ER - TY - JOUR AU - Drüeke, T. B. PY - 2007 DA - 2007// TI - Lanthanum carbonate as a first-line phosphate binder: the “cons” JO - Semin Dial VL - 20 UR - https://doi.org/10.1111/j.1525-139X.2007.00299.x DO - 10.1111/j.1525-139X.2007.00299.x ID - Drüeke2007 ER - TY - JOUR AU - Aime, S. AU - Canavese, C. AU - Stratta, P. PY - 2007 DA - 2007// TI - Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate JO - Kidney Int VL - 72 UR - https://doi.org/10.1038/sj.ki.5002503 DO - 10.1038/sj.ki.5002503 ID - Aime2007 ER - TY - JOUR AU - Frazão, J. M. AU - Adragão, T. PY - 2012 DA - 2012// TI - Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects JO - Nephron Clin Pract VL - 120 UR - https://doi.org/10.1159/000337087 DO - 10.1159/000337087 ID - Frazão2012 ER - TY - JOUR AU - Parkinson, I. S. AU - Ward, M. K. AU - Kerr, D. N. PY - 1981 DA - 1981// TI - Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis JO - J Clin Pathol VL - 34 UR - https://doi.org/10.1136/jcp.34.11.1285 DO - 10.1136/jcp.34.11.1285 ID - Parkinson1981 ER - TY - JOUR AU - Huang, W. AU - Liu, J. AU - Tang, Y. AU - Gao, X. AU - Di, B. AU - Zhang, F. PY - 2014 DA - 2014// TI - Efficacy and tolerability of lanthanum carbonate in treatment of hyperphosphatemia patients receiving dialysis--a systematic review and meta-analysis of randomized controlled trials JO - Curr Med Res Opin VL - 30 UR - https://doi.org/10.1185/03007995.2013.838551 DO - 10.1185/03007995.2013.838551 ID - Huang2014 ER - TY - JOUR AU - Shigematsu, T. PY - 2010 DA - 2010// TI - One year efficacy and safety of lanthanum carbonate for hyperphosphatemia in Japanese chronic kidney disease patients undergoing hemodialysis JO - Ther Apher Dial VL - 14 UR - https://doi.org/10.1111/j.1744-9987.2009.00697.x DO - 10.1111/j.1744-9987.2009.00697.x ID - Shigematsu2010 ER - TY - JOUR AU - Zhai, C. J. AU - Yang, X. W. AU - Sun, J. AU - Wang, R. PY - 2014 DA - 2014// TI - Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis JO - Int Urol Nephrol VL - 47 UR - https://doi.org/10.1007/s11255-014-0876-x DO - 10.1007/s11255-014-0876-x ID - Zhai2014 ER - TY - STD TI - Package insert of Fosrenol (Lanthanum Carbonate). Bayer Yakuhin, Ltd. 2013. version 8. ID - ref20 ER - TY - JOUR AU - Davis, R. L. AU - Abraham, J. L. PY - 2009 DA - 2009// TI - Lanthanum deposition in a dialysis patient JO - Nephrol Dial Transplant VL - 24 UR - https://doi.org/10.1093/ndt/gfp364 DO - 10.1093/ndt/gfp364 ID - Davis2009 ER - TY - JOUR AU - Makino, M. AU - Kawaguchi, K. AU - Shimojo, H. AU - Nakamura, H. AU - Nagasawa, M. AU - Kodama, R. PY - 2015 DA - 2015// TI - Extensive lanthanum deposition in the gastric mucosa: the first histopathological report JO - Pathol Int VL - 65 UR - https://doi.org/10.1111/pin.12227 DO - 10.1111/pin.12227 ID - Makino2015 ER - TY - JOUR AU - Namie, S. AU - Hamabe, S. AU - Kawatomi, M. AU - Oda, H. AU - Nakazawa, M. AU - Nishino, T. PY - 2015 DA - 2015// TI - Investigation of deposition of lanthanum on gastric mucosa in hemodialysis patients with lanthanum therapy JO - Nihon Toseki Igakkai Zasshi VL - 48 UR - https://doi.org/10.4009/jsdt.48.169 DO - 10.4009/jsdt.48.169 ID - Namie2015 ER - TY - JOUR AU - Haratake, J. AU - Yasunaga, C. AU - Ootani, A. AU - Shimajiri, S. AU - Matsuyama, A. AU - Hisaoka, M. PY - 2015 DA - 2015// TI - Peculiar histiocytic lesions with massive lanthanum deposition in dialysis patients treated with lanthanum carbonate JO - Am J Surg Pathol VL - 39 UR - https://doi.org/10.1097/PAS.0000000000000385 DO - 10.1097/PAS.0000000000000385 ID - Haratake2015 ER - TY - JOUR AU - Rothenberg, M. E. AU - Araya, H. AU - Longacre, T. A. AU - Pasricha, P. J. PY - 2015 DA - 2015// TI - Lanthanum-induced gastrointestinal histiocytosis JO - ACG Case Rep J VL - 2 ID - Rothenberg2015 ER - TY - JOUR AU - Block, G. A. AU - Klassen, P. S. AU - Lazarus, J. M. AU - Ofsthun, N. AU - Lowrie, E. G. AU - Chertow, G. M. PY - 2004 DA - 2004// TI - Mineral metabolism, mortality, and morbidity in maintenance hemodialysis JO - J Am Soc Nephrol VL - 15 UR - https://doi.org/10.1097/01.ASN.0000133041.27682.A2 DO - 10.1097/01.ASN.0000133041.27682.A2 ID - Block2004 ER - TY - JOUR AU - Cannata-Andía, J. B. AU - Fernandez-Martiwn, J. L. AU - Locatelli, F. PY - 2013 DA - 2013// TI - Use of phosphate-binding agents is associated with a lower risk of mortality JO - Kidney Int VL - 84 UR - https://doi.org/10.1038/ki.2013.185 DO - 10.1038/ki.2013.185 ID - Cannata-Andía2013 ER - TY - JOUR AU - Isakova, T. AU - Gutierrez, O. M. AU - Chang, Y. AU - Shah, A. AU - Tamez, H. PY - 2009 DA - 2009// TI - Phosphorus binders and survival on hemodialysis JO - J Am Soc Nephrol VL - 20 UR - https://doi.org/10.1681/ASN.2008060609 DO - 10.1681/ASN.2008060609 ID - Isakova2009 ER - TY - JOUR AU - Wilson, R. AU - Zhang, P. AU - Smyth, M. AU - Pratt, R. PY - 2009 DA - 2009// TI - Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy JO - Curr Med Res Opin VL - 25 UR - https://doi.org/10.1185/03007990903399398 DO - 10.1185/03007990903399398 ID - Wilson2009 ER - TY - JOUR AU - Komaba, H. AU - Kakuta, T. AU - Suzuki, H. AU - Hida, M. AU - Suga, T. AU - Fukagawa, M. PY - 2015 DA - 2015// TI - Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia JO - Nephrol Dial Transplant VL - 30 UR - https://doi.org/10.1093/ndt/gfu335 DO - 10.1093/ndt/gfu335 ID - Komaba2015 ER -